Spire Wealth Management Genprex, Inc. Transaction History

Spire Wealth Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	BUY	$1.82 - $3.5 $9,100 - $17,500	5,000 Added 12.5%	45,000 $102,000
Q4 2021 Jan 14, 2022	BUY	$1.21 - $2.7 $18,150 - $40,500	15,000 Added 60.0%	40,000 $52,000
Q1 2021 May 21, 2021	BUY	$3.66 - $7.67 $91,500 - $191,750	25,000 New	25,000 $108,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $39.9M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.